This is the weakest thing in our diagnostics category and we would rather say so than quietly file it alongside tests that work. The assay itself is excellent: late-night salivary cortisol screens for Cushing syndrome with roughly 92% sensitivity and 96% specificity. But that is a specific endocrine question, asked by a clinician about a patient with a reason to suspect it. Consumer stress testing is a different claim with essentially no supporting outcome evidence, the measurement is unusually fragile in exactly the unsupervised setting it is sold for, and the condition it is most often marketed against — adrenal fatigue — was the subject of a systematic review titled, straightforwardly, 'Adrenal fatigue does not exist'.
Cortisol is the body's primary glucocorticoid stress hormone, produced by the adrenal glands under the control of the hypothalamic-pituitary-adrenal (HPA) axis. It follows a pronounced daily (diurnal) rhythm, rising sharply after waking (the cortisol awakening response) and declining across the day, and can be sampled non-invasively in saliva to capture this rhythm, or measured in a segment of scalp hair, which accumulates cortisol to reflect average exposure over the preceding weeks to months. Salivary and hair cortisol are widely used in research as objective biomarkers of HPA-axis activity and chronic psychological stress.
Claims below are supported by the primary sources linked under each line — the same sources we cite on the product page.
Each line pairs a claim that circulates in marketing and forums with the trial result that contradicts or narrows it.
Quotations are verbatim from the cited paper. Negative and inconclusive trials are listed alongside the positive ones because that is the whole point of this page.
“Based on the available studies there is not firm evidence for a difference of salivary cortisol in depressed patients and control persons and salivary cortisol is unable to discriminate between persons with and without depression.”
“Salivary diurnal cortisol is measured inconsistently across RCTs, which is limiting the interpretation of findings within and across studies.”
“This systematic review of 58 studies concluded that “adrenal fatigue” does not exist as a recognised condition.”
“Late-night salivary cortisol screens for Cushing syndrome with pooled 92% sensitivity and 96% specificity across 7 studies (947 patients).”
“Flatter slopes in cortisol decline across the day were associated with increased risk of all-cause mortality (hazard ratio for 1 sd reduction in slope steepness 1.30; 95% confidence interval (CI) = 1.09-1.55).”
Across large studies, dysregulated cortisol patterns track with worse health: a meta-analysis found flatter daily cortisol slopes are associated with poorer mental and physical health, the Whitehall II cohort linked flatter salivary slopes to higher all-cause and cardiovascular mortality, and elevated hair cortisol has been tied to hypertension and incident cardiovascular disease. Salivary cortisol does have validated clinical uses — late-night values screen for Cushing syndrome with roughly 92% sensitivity and 96% specificity — and the cortisol awakening response reproducibly tracks psychosocial stress across 147 studies. However, associations with general health are typically modest, cortisol values are highly variable and sensitive to collection method, time of day, hair color and analytic technique, and some analyses (such as salivary cortisol in depression) find it cannot reliably distinguish affected from unaffected people, so a single consumer test has limited diagnostic value for an individual. This evidence concerns cortisol as a biomarker of stress and HPA-axis function in general, not this specific commercial saliva testing product.
A grade that cannot be falsified is a marketing claim. These are the specific results that would move this one up.
If you have symptoms that worry you — persistent fatigue, unexplained weight change, muscle weakness, easy bruising, new high blood pressure — those are reasons to see a physician, who can order the right test for the right question, including salivary cortisol if it is indicated. If you feel stressed and want to act on it, sleep, exercise, and reducing the actual stressor are the interventions with evidence, and none of them requires a $129.95 saliva kit to justify starting. If you want to spend money on a home measurement that has outcome evidence behind it, buy a blood pressure cuff.
We are not putting a buy button on this page. The product page stays up, with the same grade and the same reasoning, so you can see exactly what we think of it: Saliva Cortisol Stress Test — graded Preliminary →
Graded Strong. A number with unambiguous outcome evidence, a defined target, and a treatment pathway attached.
A lipid measurement that maps to cardiovascular risk more cleanly than the panel most labs print by default.
An inflammation marker with actual prognostic literature — and a page that explains why one high reading means retest, not panic.
How to tell a home test that means something from one that does not.
Cortisol molecule page · hs-CRP: one high reading means retest, not panic · Biological age tests: the reliability problem nobody advertises · Saliva cortisol stress test — the graded product page · Diagnostics and epigenetic tests · The full evidence record
Sibling pages in this record: NMN (nicotinamide mononucleotide) · Resveratrol · Vitamin D · Omega-3 fish oil
Yes — for a specific clinical question. Late-night salivary cortisol is one of the recommended first-line tests for suspected Cushing syndrome, with pooled sensitivity around 92% and specificity around 96%. That is a clinician ordering a test because a patient has features suggesting a specific endocrine disease. It is not the same product as a consumer stress panel.
It is not a recognised diagnosis. A systematic review published in BMC Endocrine Disorders and titled 'Adrenal fatigue does not exist' reviewed the literature and reached that conclusion. Adrenal insufficiency is a real and serious condition with defined diagnostic criteria — it is a different thing, and it is diagnosed by a clinician.
Because the analyte is real but the consumer claim built on it has essentially no supporting outcome evidence. Our measurement-tool grade is for tests where the marker predicts something and the test measures it reliably. Here the marker predicts something at the population level, and the consumer format does not reliably measure it — different problem, lower grade.
Then you have a result whose reproducibility depends on sample timing nobody verified, with no defined intervention attached to it. In practice most people take that result to a clinician, who will repeat the workup properly if the clinical picture warrants. That is a reason to start with the clinician.